Richardpruen (talk | contribs) No edit summary |
Richardpruen (talk | contribs) |
||
| Line 37: | Line 37: | ||
==While some rodent studies suggest impaired cognitive development from nicotine administration in adolescence (2016 [https://www.cdc.gov/tobacco/data_statistics/sgr/e-cigarettes/index.htm Surgeon General’s Report]) similar rodent studies exist for caffeine.== | ==While some rodent studies suggest impaired cognitive development from nicotine administration in adolescence (2016 [https://www.cdc.gov/tobacco/data_statistics/sgr/e-cigarettes/index.htm Surgeon General’s Report]) similar rodent studies exist for caffeine.== | ||
== 2010 [https://pubmed.ncbi.nlm.nih.gov/20414766/ Meta-analysis of the acute effects of nicotine and smoking on human performance] and 2012 | == 2010 [https://pubmed.ncbi.nlm.nih.gov/20414766/ Meta-analysis of the acute effects of nicotine and smoking on human performance] and 2012 [Nicotine treatment of mild cognitive impairment A 6-month double-blind pilot clinical trial|https://n.neurology.org/content/78/2/91.short]== | ||
*Clinical studies suggest some cognitive improvements as a result of nicotine. | *Clinical studies suggest some cognitive improvements as a result of nicotine. | ||
== 2017 [https://www.ncbi.nlm.nih.gov/pubmed/27940486 Moist smokeless tobacco (Snus) use and risk of Parkinson's disease]== | == 2017 [https://www.ncbi.nlm.nih.gov/pubmed/27940486 Moist smokeless tobacco (Snus) use and risk of Parkinson's disease]== | ||
edits